Matinas生物制药（MTNB.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他58.87%
私营企业23.31%
个人与内部人士11.49%
机构投资者6.34%

主要股东

主要股东最新
股东
Hezbay Holdings Llc	20.39%	130.65 万	16.43%	+105.26 万	2026/07/13
David Lazar	8.51%	54.50 万	0.00%	+0	2025/08/15
111 Equity Group LLC	2.87%	18.36 万	0.00%	+0	2025/02/13
Adam SternFormer Director	2.78%	17.82 万	0.00%	+0	2025/04/08
Geode Capital Management, LLC	1.02%	6.52 万	0.14%	+9,200.00	2026/03/31
Vanguard Capital Management, LLC	0.91%	5.84 万	--	+5.84 万	2026/03/31
Citadel Advisors LLC	0.81%	5.17 万	0.22%	-1.40 万	2026/03/31
BlackRock, Inc.	0.78%	5.03 万	<0.01%	+612.00	2026/06/30
Holos Integrated Wealth, LLC	0.51%	3.25 万	0.00%	+0	2026/06/30
Renaissance Technologies LLC	0.45%	2.86 万	<0.01%	-400.00	2026/03/31
AKS Family Foundation	0.41%	2.65 万	0.00%	+0	2025/04/08
Stern Aegis Ventures, Llc Defined Benefit Plan	0.33%	2.14 万	0.00%	+0	2025/02/13
XTX Markets Limited	0.32%	2.07 万	0.06%	+3,797.00	2026/03/31
State Street Investment Management	0.24%	1.53 万	0.00%	+0	2026/06/30
Susquehanna International Group, LLP	0.22%	1.43 万	0.11%	-6,785.00	2026/03/31
Sargent Investment Group, LLC	0.20%	1.27 万	0.00%	+0	2026/03/31
Jerome JabbourCo-Founder, Chairman, CEO, President & Interim CFO	0.14%	9,207.00	0.00%	+0	2025/05/09
Pavilion Capital Partners LLC	0.09%	6,000.00	0.00%	+0	2025/04/08
Tower Research Capital Europe Limited	0.04%	2,853.00	<0.01%	-8.00	2026/03/31
Keith KucinskiFormer Chief Financial Officer	0.03%	1,890.00	0.00%	+0	2025/05/09